Patents Issued in September 30, 2014
-
Patent number: 8846343Abstract: Provided is a novel high-expression promoter, namely a GAL1 promoter, derived from Kluyveromyces marxianus. Also provided are the following, characterized by the use of the provided high-expression promoter; a recombinant polynucleotide containing said high-expression promoter; a vector containing said recombinant polynucleotide; a transformant obtained by introducing said recombinant polynucleotide or vector into yeast; a method using said transformant for high expression of a target gene; and a method using said transformant to manufacture the gene product of a target gene.Type: GrantFiled: February 7, 2011Date of Patent: September 30, 2014Assignee: Yamaguchi UniversityInventors: Rinji Akada, Hisashi Hoshida, Masamitsu Ide
-
Patent number: 8846344Abstract: The present invention relates to a process for the purification of a glycoprotein comprising subjecting a liquid containing said glycoprotein to the steps of: a) reverse phase chromatography, b) size exclusion chromatography, and c) hydrophobic interaction chromatography. Also provided is a manufacturing process for producing a glycoprotein of interest.Type: GrantFiled: November 24, 2010Date of Patent: September 30, 2014Assignee: Glycotope GmbHInventors: Steffen Goletz, Lars Stockl
-
Patent number: 8846345Abstract: The invention relates to a recombinant cell line capable of inducible expression of an ? and/or ?subunit of interleukin 12 (IL-12), and an ecdosyme-inducible expression vector capable of transfecting a host cell to produce the recombinant cell line of the invention. The invention also relates to a method of screening a candidate compound for the ability to inhibit IL-12 formation and secretion which comprises the steps of incubating a cell line according to the invention with the candidate compound and then assaying the cell line culture for secreted IL-12, or a subunit thereof.Type: GrantFiled: December 8, 2003Date of Patent: September 30, 2014Assignee: The Queen's University of BelfastInventors: Koen Vandenbroeck, Iraide Alloza
-
Patent number: 8846346Abstract: The present invention relates to soluble C-terminal fragments of the adiponectin receptor and their use in the diagnosis and management of disorders.Type: GrantFiled: December 15, 2011Date of Patent: September 30, 2014Assignee: Siemens Healthcare Diagnostics Inc.Inventor: Michael Pugia
-
Patent number: 8846347Abstract: The invention provides methods for preparing DNA sequencing libraries by assembling short read sequencing data into longer contiguous sequences for genome assembly, full length cDNA sequencing, metagenomics, and the analysis of repetitive sequences of assembled genomes.Type: GrantFiled: February 5, 2013Date of Patent: September 30, 2014Assignee: University of WashingtonInventors: Jay Shendure, Joseph Hiatt, Rupali Patwardhan, Emily Turner
-
Patent number: 8846348Abstract: The present invention relates to kits and methods for efficiently generating 5? capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5?-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5?-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5?-diphosphate with detectable dye or enzyme moieties.Type: GrantFiled: February 20, 2014Date of Patent: September 30, 2014Assignee: CellScript, LLCInventors: Jerome Jendrisak, Ronald Meis, Gary Dahl
-
Patent number: 8846349Abstract: This invention relates to a rapid method for detection and characterization of Escherichia coli bacteria serotype O157:H7 based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. This method is preferably employed to detect E. coli O157:H7 in a food or water sample, such as a beef enrichment. The present invention further relates to replication compositions and kits for carrying out the method of the present invention.Type: GrantFiled: July 20, 2010Date of Patent: September 30, 2014Assignee: E.I. du Pont de Nemours and CompanyInventor: Frank R. Burns
-
Patent number: 8846350Abstract: The present invention provides methods and kits for determining which microRNAs bind to a target mRNA where the methods comprise the steps of (a) creating a bait sequence from the target mRNA, where the bait sequence comprises a label that binds to a binding agent; (b) adding a mixture of microRNAs to the bait sequence; (c) separating the microRNAs that bind to the bait sequence from those microRNAs that do not bind; and (d) identifying the microRNAs that bind to the bait sequence, wherein the microRNAs identified are those that bind to the target mRNA.Type: GrantFiled: October 18, 2010Date of Patent: September 30, 2014Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Simon D. Spivack, Miao Shi, Weiguo Han
-
Patent number: 8846351Abstract: The present invention relates to compositions comprising a GH61 polypeptide having cellulolytic enhancing activity and an organic compound comprising a carboxylic acid moiety, a lactone moiety, a phenolic moiety, a flavonoid moiety, or a combination thereof, wherein the combination of the GH61 polypeptide having cellulolytic enhancing activity and the organic compound enhances hydrolysis of a cellulosic material by a cellulolytic enzyme compared to the GH61 polypeptide alone or the organic compound alone. The present invention also relates to methods of using the compositions.Type: GrantFiled: August 5, 2011Date of Patent: September 30, 2014Assignees: Novozymes, Inc., Novozymes A/SInventors: Jason Quinlan, Feng Xu, Matthew Sweeney, Katja Salomon Johansen
-
Patent number: 8846352Abstract: The invention provides methods of cultivating oil-bearing microbes using xylose as a fixed carbon source. Also provided are microorganisms that have been genetically engineered to metabolize xylose as a fixed carbon source allowing them to convert xylose into oils. Particular advantages of the processes provided herein include production of oils rather than alcohols through the microbial fermentation processes utilizing xylose.Type: GrantFiled: May 4, 2012Date of Patent: September 30, 2014Assignee: Solazyme, Inc.Inventors: Penelope Chua, Aravind Somanchi
-
Patent number: 8846353Abstract: Preparation of derivatives of ?-hydroxycarboxylic acid, including ?-hydroxycarboxylic acid esters, ?,?-unsaturated carboxylic acid, esters of ?,?-unsaturated carboxylic acid, and alkoxy derivatives, such as preparation of acrylic acid from 3-hydroxypropionic acid.Type: GrantFiled: December 18, 2012Date of Patent: September 30, 2014Assignee: Cargill, IncorporatedInventors: Paraskevas Tsobanakis, Xiangsheng Meng, Timothy Walter Abraham
-
Patent number: 8846354Abstract: Organic acid-producing microorganisms and methods of using same. The organic acid-producing microorganisms comprise modifications that reduce or ablate AcsA activity or AcsA homolog activity. The modifications increase tolerance of the microorganisms to such organic acids as 3-hydroxypropionic acid, acrylic acid, propionic acid, lactic acid, and others. Further modifications to the microorganisms increase production of such organic acids as 3-hydroxypropionic acid, lactate, and others. Methods of producing such organic acids as 3-hydroxypropionic acid, lactate, and others with the modified microorganisms are provided. Methods of using acsA or homologs thereof as counter-selectable markers are also provided.Type: GrantFiled: March 7, 2014Date of Patent: September 30, 2014Assignee: Wisconsin Alumni Research FoundationInventors: Brian Frederick Pfleger, Matthew Brett Begemann
-
Patent number: 8846355Abstract: A method for degrading a readily degradable resin composition comprising an aliphatic polyester (A) which is biodegradable, and an aliphatic polyester (B?) which releases an acid upon hydrolysis and which is biodegradable at a higher degradation rate than that of the aliphatic polyester (A), the method comprising degrading the readily degradable resin composition in an enzyme reaction liquid containing a degradation enzyme, and an acid neutralizing agent incompatible with the enzyme reaction liquid.Type: GrantFiled: June 27, 2013Date of Patent: September 30, 2014Assignee: Toyo Seikan Kaisha, Ltd.Inventors: Seishi Yoshikawa, Tsutaki Katayama, Masahito Kogure
-
Patent number: 8846356Abstract: Biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) is processed to produce useful products, such as fuels. For example, systems are described that can use feedstock materials, such as cellulosic and/or lignocellulosic materials, to produce ethanol and/or butanol, e.g., by fermentation.Type: GrantFiled: April 9, 2013Date of Patent: September 30, 2014Assignee: Xyleco, Inc.Inventor: Marshall Medoff
-
Patent number: 8846357Abstract: Though chlorine dioxide is generally used to control bacterial contamination, a method was developed which allows the use of stabilized chlorine dioxide (SCD) for controlling contamination during fermentation that uses the bacteria Zymomonas as the biocatalyst, even though Zymomonas is sensitive to chlorine dioxide. Parameters were identified for inoculating a composition for fermentation with Zymomonas cells after a time period has elapsed following SCD addition.Type: GrantFiled: December 20, 2012Date of Patent: September 30, 2014Assignee: E I du Pont de Nemours and CompanyInventors: Maria C Leana, Brian G Lefebvre
-
Patent number: 8846358Abstract: In a step of contacting an organic material including formic acid ions and a carbon source other than the formic acid ions with a microorganism having a formate dehydrogenase gene and a hydrogenase gene under an anaerobic condition, concentration of the formic acid ions in the organic material is set to be not less than 0.01 mol/L and not more than 0.5 mol/L, and concentration of the carbon source is set to not less than 0.1 mmol/L and not more than 200 mmol/L. This allows continuously producing hydrogen for a long time, without dropping the ability of the microorganism to produce hydrogen.Type: GrantFiled: May 5, 2009Date of Patent: September 30, 2014Assignees: Sharp Kabushiki Kaisha, Research Institute of Innovative Technology for the EarthInventors: Akihito Yoshida, Hideaki Yukawa, Masayuki Inui
-
Patent number: 8846359Abstract: A method of regenerating an enzymatic catalyst arranged in a reactor includes a mineral support based on metal oxide and at least one enzyme, wherein it contains at least one step of detachment of the spent enzymes by solvation by scavenging of the catalyst using at least one ionic surfactant, and at least one step of re-attachment of active enzymes by scavenging of the purified support with at least one solution of active enzymes, the two steps being performed in situ within the reactor.Type: GrantFiled: September 20, 2012Date of Patent: September 30, 2014Assignee: Total Marketing ServicesInventors: Daniel Thomas, Sylviane Pulvin, Lotfi Hedhli, Samuel Djelassi
-
Patent number: 8846360Abstract: A novel activating enzyme for ubiquitin, Uba6, is provided. Compositions and methods for inhibiting ubiquitin via the Uba6 pathway are provided. Methods of identifying novel inhibitors of ubiquitination are also provided. Novel RNAi molecules are also provided.Type: GrantFiled: May 9, 2012Date of Patent: September 30, 2014Assignee: President and Fellows of Harvard CollegeInventors: Jeffrey Wade Harper, Jianping Jin
-
Patent number: 8846361Abstract: The present invention relates to solid enzyme, in particular phytase, compositions stabilized with a lactic acid source such as Corn Steep Liquor (CSL), and methods of producing the same. Preferred compositions additionally comprise starch and disaccharides such as lactose or trehalose.Type: GrantFiled: March 13, 2009Date of Patent: September 30, 2014Assignee: Novozymes A/SInventors: Lotte Rugholm Henriksen, Erik Marcussen
-
Patent number: 8846362Abstract: The present disclosure provides acyltransferases useful for synthesizing therapeutically important statin compound.Type: GrantFiled: January 31, 2013Date of Patent: September 30, 2014Assignee: Codexis, Inc.Inventors: Lynne Gilson, Steven James Collier, Joly Sukumaran, Wan Lin Yeo, Oscar Alvizo, Ee Ling Teo, Robert John Wilson, Junye Xu
-
Patent number: 8846363Abstract: This invention is related, in part, to sulfatase enzymes and methods of their use.Type: GrantFiled: October 22, 2010Date of Patent: September 30, 2014Inventors: James R. Myette, Ram Sasisekharan
-
Patent number: 8846364Abstract: The present invention relates to protein engineering, and concerns especially family G/11 xylanases, and genes encoding said enzymes. In specific, the invention concerns Trichoderma reesei XYNII gene, which codes for endo-1,4-?-xylanase (EC 3.2.1.8). The invention describes how site-directed mutagenesis can be used to improve the properties of an enzyme to match the industrial conditions where it is used. Protein engineering can be used to improve thermoactivity and thermostability of xylanases, as well as to broaden their pH range.Type: GrantFiled: March 22, 2013Date of Patent: September 30, 2014Assignee: Danisco US Inc.Inventors: Fred Fenel, Ossi Turunen, Matti Leisola
-
Patent number: 8846365Abstract: Phosphate biosensors are disclosed, which comprise a phosphate binding domain conjugated to donor and fluorescent moieties that permit detection and measurement of Fluorescence Resonance Energy Transfer upon phosphate binding. Such biosensors are useful for real time monitoring of phosphate metabolism in living cells.Type: GrantFiled: October 14, 2005Date of Patent: September 30, 2014Assignee: Carnegie Institution of WashingtonInventors: Wolf B. Frommer, Hong Gu, Sylvie Lalonde, Arthur Grossman
-
Patent number: 8846366Abstract: The invention relates to R-hydroxynitrile lyases with improved substrate acceptance, increased activity and increased selectivity, obtainable by introducing random mutations with the aid of random mutagenesis and/or saturation mutagenesis techniques, identifying by means of screening or selection and, where appropriate, subsequently combining advantageous mutations, and to the use thereof.Type: GrantFiled: December 11, 2007Date of Patent: September 30, 2014Assignee: DSM IP Assets BVInventors: Richard Gaisberger, Anton Glieder, Zhibin Liu, Beate Pscheidt
-
Patent number: 8846367Abstract: Provided is a phenol-producing transformant constructed by transferring a gene which encodes an enzyme having tyrosine phenol-lyase activity into a coryneform bacterium as a host. Also provided is a process for producing phenol, which comprises a step of allowing the transformant to react in a reaction mixture containing tyrosine, a salt thereof, or an ester thereof under reducing conditions, and a step of collecting phenol from the reaction mixture.Type: GrantFiled: November 17, 2011Date of Patent: September 30, 2014Inventors: Hideaki Yukawa, Masayuki Inui
-
Patent number: 8846368Abstract: Disclosed herein is a novel bacteriophage which has specific bactericidal activity against one or more Salmonella bacteria selected from the group consisting of Salmonella enteritidis, Salmonella typhimurium, Salmonella gallinarum, and Salmonella pullorum without affecting beneficial bacteria, in addition to showing excellent tolerance to acid, heat and desiccation. The novel bacteriophage of the present invention can be widely used as an active ingredient for therapeutic agents, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused by Salmonella enteritidis, Salmonella typhimurium, Salmonella gallinarum or Salmonella pullorum including salmonellosis, Salmonella food poisoning, Fowl Typhoid, and Pullorum disease or for controlling the Salmonella bacteria.Type: GrantFiled: September 17, 2012Date of Patent: September 30, 2014Assignee: CJ Cheiljedang CorporationInventors: Soo An Shin, Min Tae Park, Hyang Choi, Young Wook Cho, In Hye Kang, Su Jin Choi
-
Patent number: 8846369Abstract: A cyanobacterial host cell, Cyanobacterium sp., that harbors at least one recombinant gene for the production of a chemical compounds is provided, as well as vectors derived from an endogenous plasmid isolated from the cell.Type: GrantFiled: September 30, 2013Date of Patent: September 30, 2014Assignee: Algenol Biofuels Inc.Inventors: Irina Piven, Alexandra Friedrich, Ulf Dühring, Frank Uliczka, Kerstin Baier, Masami Inaba, Tuo Shi, Kui Wang, Heike Enke, Dan Kramer
-
Patent number: 8846370Abstract: The described invention provides genetically engineered microorganisms, including photosynthetic microorganisms, expressing 4-hydroxybenzoyl-CoA thioesterases and methods of using the genetically engineered microorganisms for producing free fatty acids and/or fatty acid derivatives.Type: GrantFiled: December 13, 2011Date of Patent: September 30, 2014Assignee: ExxonMobil Research and Engineering CompanyInventors: Robert Christopher Brown, Rekha Seshadri, Carlos Chavez-Torres, Weidong Xu, Toby Richardson
-
Patent number: 8846371Abstract: Compositions and methods for producing aldehydes, alkanes, and alkenes are described herein. The aldehydes, alkanes, and alkenes can be used in biofuels.Type: GrantFiled: September 24, 2012Date of Patent: September 30, 2014Assignee: REG Life Sciences, LLC.Inventors: Andreas W. Schirmer, Mathew A. Rude, Shane A. Brubaker
-
Patent number: 8846372Abstract: The use of free, extractable lipids found in bacteria for identification of bacterial species and subspecies is described. Bacteria have been found to differ sufficiently in their extracted lipid compositions to effect identification using thin layer chromatographic techniques. Burkholderia pseudomallei, Burkholderia thailandensis, and Burkholderia mallei have been distinguished in this manner. Lipopeptides specific to Mycobacterium avium subspecies paratuberculosis, but not to the closely related bacterium Mycobacterium avium subspecies avium have also been used as a basis for bacterial subspecies identification using mass spectrometry and seroreactivity.Type: GrantFiled: December 2, 2010Date of Patent: September 30, 2014Assignee: Colorado State University Research FoundationInventors: Torsten Manfred Eckstein, Julia Mitsue Inamine Eckstein
-
Patent number: 8846373Abstract: The present invention relates to new methods to promote sialylation of glycoconjugates, including recombinant glycoproteins, in glycoconjugate production systems. The invention relates to methods to promote efficient glycoconjugate sialylation in recombinant expression systems, by providing simpler and more economical ways to produce large intracellular pools of sialic acid precursors. The invention is directed to nucleic acids, vectors, and cells harboring vectors comprising nucleic acids encoding enzymes involved in the synthesis of sialic acid precursors, and cells harboring these nucleic acids in combination with nucleic acids encoding glycosyltransferases, including sialyltransferases, to facilitate the production of humanized recombinant glycoproteins in bacterial, fungal, plant, and animal cell expression systems.Type: GrantFiled: July 27, 2012Date of Patent: September 30, 2014Assignee: The University of WyomingInventors: Christoph Geisler, Donald Jarvis
-
Patent number: 8846374Abstract: Engineered strains of the oleaginous yeast Yarrowia lipolytica capable of producing carotenoids (e.g., ?-carotene, lycopene, lutein, zeaxanthin, canthaxanthin, astaxanthin) are provided. The strains may also be engineered to co-produce at least one ?-3/?-6 polyunsaturated fatty acid and/or at least one additional antioxidant. Methods of using the carotenoid products obtained (e.g., biomass and/or pigmented oils) in food and feed applications are also provided.Type: GrantFiled: December 7, 2007Date of Patent: September 30, 2014Assignee: E I du Pont de Nemours and CompanyInventors: Pamela L. Sharpe, Rick W. Ye, Quinn Qun Zhu
-
Patent number: 8846375Abstract: Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type.Type: GrantFiled: July 12, 2013Date of Patent: September 30, 2014Assignee: Solazyme, Inc.Inventors: Scott Franklin, Aravind Somanchi, George Rudenko, Riyaz Bhat, Xinhua Zhao, Risha Bond, Walter Rakitsky, Alejandro Marangoni, Diza Braksmayer
-
Patent number: 8846376Abstract: A heavy metal-resistant recombinant bacterium capable to remove mercury (II) species, cadmium and copper (II) in presence of other heavy metals from polluted sites, which corresponds to Cupriavidus metallidurans strain MSR33, deposited under the access number NRRL B-50299, a product for the bioremediation of environments contaminated with heavy metals, where the product includes a bacterial inoculum of this recombinant strain, the process of obtaining the product and a method for the bioremediation of environments contaminated with heavy metals, which uses this product for the bioremediation.Type: GrantFiled: December 20, 2010Date of Patent: September 30, 2014Assignee: Universidad Tecnica Federico Santa MariaInventors: Michael Seeger Pfeiffer, Luis Antonio Rojas Araya, Myriam Lydia Gonzalez Vergara, Carolina Elvira Maria Ya{circumflex over (n)}ez Prieto
-
Patent number: 8846377Abstract: A process for capturing CO2 includes contacting a CO2-containing gas with an absorption mixture optionally within a packed reactor is provided. The absorption mixture includes a liquid solution and micro-particles. The micro-particles include a support material and biocatalyst supported by the support material and are sized and provided in a concentration such that the absorption mixture flows through the packed reactor and that the micro-particles are carried with the liquid solution to promote dissolution and transformation of CO2 into bicarbonate and hydrogen ions. The absorption mixture and micro-particles may be provided in an absorption reactor so as to be pumpable. Furthermore, a process for desorbing CO2 gas from an ion-rich aqueous mixture includes providing biocatalytic micro-particles and feeding the mixture to a desorption reactor, to promote transformation of the bicarbonate and hydrogen ions into CO2 gas and water.Type: GrantFiled: August 4, 2010Date of Patent: September 30, 2014Assignee: CO2 Solutions Inc.Inventors: Sylvie Fradette, Julie Gingras, Normand Voyer, Jonathan Carley, Glenn R. Kelly, Olivera Ceperkovic
-
Patent number: 8846378Abstract: Fluidic circuits and methods of using same are provided herein. In some embodiments, the circuit can direct different fluids to a common volume, such as a reaction chamber or flow cell, without intermixing or cross contamination. The direction and rate of flow through junctions, nodes and passages of the fluidics circuit can be controlled, for example, by the states of upstream valves, differential fluid pressures at circuit inlets or upstream reservoirs, or flow path resistances. Free diffusion or leakage of fluids from unselected inlets into the common outlet or other inlets at junctions or nodes can be prevented by the flow of the selected inlet fluid, a portion of which can sweep by the inlets of unselected fluids and exit the fluidics circuit by waste ports.Type: GrantFiled: September 26, 2011Date of Patent: September 30, 2014Assignee: Life Technologies CorporationInventors: Jonathan Schultz, David Marran
-
Patent number: 8846379Abstract: A system and method for micromanipulating samples are described to perform automatic, reliable, and high-throughput sample microinjection of foreign genetic materials, proteins, and other molecules, as well as drawing genetic materials, proteins, and other molecules from the sample. The system and method overcome the problems inherent in traditional manual micromanipulation that is characterized by poor reproducibility, human fatigue, and low throughput. The present invention is particularly suited for adherent cell microinjection but can be readily extended to aspiration, isolation, and electrophysiological measurements of microorganisms, unicellular organisms, or cells.Type: GrantFiled: March 19, 2008Date of Patent: September 30, 2014Inventors: Yu Sun, Wenhui Wang
-
Patent number: 8846380Abstract: A reaction cassette for a glycated hemoglobin meter and a measuring method thereof are provided. The reaction cassette for the glycated hemoglobin meter includes: a first zone receiving a first reagent and a blood sample; a second zone receiving a second reagent; a reaction zone in which the blood sample reacts with the first reagent, or through which the second reagent passes to react with a first blood sample mixture obtained by reacting the blood sample with the first reagent; and a measurement zone measuring an amount of total hemoglobin in the first blood sample mixture, or measuring an amount of glycated hemoglobin in a second blood sample mixture obtained by reacting the first blood sample mixture with the second reagent, wherein the blood sample, the first reagent, and the second reagent move between the reaction zone and the measurement zone according to a rotation angle of the reaction cassette when the reaction cassette is rotated.Type: GrantFiled: February 4, 2008Date of Patent: September 30, 2014Assignee: Infopia Co., Ltd.Inventors: Byeong-woo Bae, Sung-dong Lee, Min-sun Kim, Jae-hyun Yoo, Hyoung-soo Kim, Ki-won Lee, Ju-pyo Hong
-
Patent number: 8846381Abstract: A biogas desulfurization device comprises an anaerobic system, a desulfurization liquid circulating system, an oxygen supply device and a desulfurization system, wherein the anaerobic system is used for generating biogas and filling the generated biogas into the desulfurization system, the desulfurization liquid circulating system is used for filling the desulfurization liquid into the desulfurization system and recycling the desulfurization liquid that has undergone the desulfurization operation, the oxygen supply device is used for filling air into the desulfurization system, and the desulfurization system which comprises at least one stage desulfurization tower group is used for carrying out the desulfurization operation on the biogas from the anaerobic system, the desulfurization operation is conducted by the desulfurization liquid received from the desulfurization liquid circulating system in an aerobic environment.Type: GrantFiled: April 21, 2011Date of Patent: September 30, 2014Assignee: Beijing Helee Bio-Energy Technology Co., Ltd.Inventor: Wenzhi Pan
-
Patent number: 8846382Abstract: The present invention is concerned with a fluid circulation apparatus for use as a bioreactor or the like, the apparatus comprising a flexible bag like container within which is disposed a collapsible and at least partially inflatable draft tube which is tethered to a base of the container such that when inflated the draft tube rises off the base and maintains the correct shape as a result of the inflation thereof, and which includes perforations in order to allow the inflation gas to escape and rise upwardly through the draft tube to generate counter current circulation within the container.Type: GrantFiled: July 31, 2007Date of Patent: September 30, 2014Inventor: Oliver Muecke
-
Patent number: 8846383Abstract: Disclosed are a method and a device for the biotechnological production of valuable products, in which a medium is fed to a bioreactor and is subjected to a fermentation process, the valuable product is gathered as a filtered permeate and/or concentrated retentate via a cross-flow filtration system that is mounted downstream thereof, and residues are once again fed to the bioreactor until being gathered as a retentate. Other materials can be fed to the bioreactor in a controlled manner in addition to the medium while the concentrated retentate and permeate can be gathered in a controlled manner. The fermentation process and the filtration process are regulated in a synchronized manner in an integrated system via a digital control unit.Type: GrantFiled: June 21, 2003Date of Patent: September 30, 2014Assignee: Sartorius AGInventors: Reiner Luttmann, Wilfried Kappel, Toralf Gliem, Mohammad Saeed Ajam, Lars Boettcher, Bernd-Ulrich Wilhelm, Wolfgang Rietschel
-
Patent number: 8846384Abstract: The present invention relates to a system for detecting microbial contamination of a liquid specimen comprising a device for concentrating micro-organisms from a liquid specimen, having (i) a hyperbaric chamber, (ii) a filter housing comprising a liquid-permeable bed of an adsorbent material and adapted for being fluidly connected to the hyperbaric chamber, and (iii) a manner for pressurizing the hyperbaric chamber. The system also comprises a kit for detection of micro-organisms adsorbed to the adsorbent material, wherein the kit is based on enzymatic detection using chromogenic and/or fluorescent substrate analogues.Type: GrantFiled: November 24, 2008Date of Patent: September 30, 2014Assignee: Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNOInventors: Jan Gerritse, Johannes Wouterus van Groenestijn, Neeltje Dina Zegers
-
Patent number: 8846385Abstract: Lentiviral vectors modified at the 5? LTR or both the 5? and 3? LTR's are useful in the production of recombinant lentivirus vectors. Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production.Type: GrantFiled: July 26, 2006Date of Patent: September 30, 2014Assignee: GBP IP, LLCInventors: Luigi Naldini, Thomas Dull, Deborah A. Farson, Rochelle Witt
-
Patent number: 8846386Abstract: Disclosed herein are nucleic acid molecules comprising a nucleotide sequence of sVEGF-2, proteins encoded by those sequences and antibodies that bind to the protein. Also disclosed are methods for inhibiting or enhancing expression or activity of sVEGFR-2 and methods for inhibiting graft rejection, particularly cornea graph rejection. Also described are methods for inhibiting lymphangiogenesis and lymphatic endothelial cell proliferation by administering an effective amount of sVEGFR-2 and methods for treating lymphedema by inhibiting the activity of sVEGFR-2.Type: GrantFiled: December 18, 2008Date of Patent: September 30, 2014Assignee: University of Kentucky Research FoundationInventors: Jayakrishna Ambati, Rumulo J. C. Albuquerque
-
Patent number: 8846387Abstract: This invention provides methods for obtaining targeted gene modification in vertebrate cells using parvoviral vectors, including adeno-associated virus (AAV). The parvoviral vectors used in the methods of the invention are capable of targeting a specific genetic modification to a preselected target locus in a cellular genome by homologous pairing.Type: GrantFiled: May 24, 2011Date of Patent: September 30, 2014Assignee: The University of WashingtonInventors: David W. Russell, Roli K. Hirata
-
Patent number: 8846388Abstract: The present invention is directed to novel nucleotide and amino acid sequences of Torque teno virus (“TTV”), including novel genotypes thereof, all of which are useful in the preparation of vaccines for treating and preventing diseases in swine and other animals. Vaccines provided according to the practice of the invention are effective against multiple swine TTV genotypes and isolates. Diagnostic and therapeutic polyclonal and monoclonal antibodies are also a feature of the present invention, as are infectious clones useful in the propagation of the virus and in the preparation of vaccines. Particularly important aspects of the invention include vaccines that provide TTV ORF1 protein, or peptide fragments thereof, as antigen.Type: GrantFiled: April 16, 2010Date of Patent: September 30, 2014Assignee: Zoetis LLCInventors: Gregory Paul Nitzel, Robert Gerard Ankenbauer, Jay Gregory Calvert, Donna Steuerwald Dunyak, Jacqueline Gayle Marx, Nancee Lois Oien, Douglas Steven Pearce, Mira Ivanova Stoeva, James Richard Thompson
-
Patent number: 8846389Abstract: The present invention provides an adeno-associated virus 4 (AAV4) virus and vectors and particles derived therefrom. In addition, the present invention provides methods of delivering a nucleic acid to a cell using the AAV4 vectors and particles.Type: GrantFiled: July 2, 2013Date of Patent: September 30, 2014Assignee: The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: John A. Chiorini, Robert M. Kotin, Brian Safer
-
Patent number: 8846390Abstract: Methods for the conditioning of bioprosthetic material employ bovine pericardial membrane. A laser directed at the fibrous surface of the membrane and moved relative thereto reduces the thickness of the membrane to a specific uniform thickness and smoothes the surface. The wavelength, power and pulse rate of the laser are selected which will smooth the fibrous surface as well as ablate the surface to the appropriate thickness. Alternatively, a dermatome is used to remove a layer of material from the fibrous surface of the membrane. Thinning may also employ compression. Stepwise compression with cross-linking to stabilize the membrane is used to avoid damaging the membrane through inelastic compression. Rather, the membrane is bound in the elastic compressed state through addition cross-linking. The foregoing several thinning techniques may be employed together to achieve strong thin membranes.Type: GrantFiled: March 23, 2011Date of Patent: September 30, 2014Assignee: Edwards Lifesciences CorporationInventors: Jeffrey S. Dove, Bin Tian, Ralph Schneider, Jeffrey S. Cohen, Ivan Jankovic, John F. Migliazza, Gregory A. Wright, James M. Young, Louis A. Campbell
-
Patent number: 8846391Abstract: The invention provides methods for sensitive and specific detection of anti-HSV-2 antibodies by depletion of cross-reactive (non-specific) antibodies in a biological sample that can lead to a false positive result. The invention also features compositions, including nucleic acids, polypeptides, and kits, for use in the methods of the invention.Type: GrantFiled: June 23, 2010Date of Patent: September 30, 2014Assignee: Focus Diagnostics, Inc.Inventors: Xin Su, Lilly Kong, Wayne Hogrefe
-
Patent number: 8846392Abstract: The present application relates to stem cells isolated from various sources within the body of a patient or of a healthy donor and identified by the presence of the interleukin 12 (IL-12) receptor. The present application also provides methods for making and for using the stem cells.Type: GrantFiled: September 27, 2011Date of Patent: September 30, 2014Assignee: Neumedicines, Inc.Inventors: Lena A. Basile, Timothy Kirk Gallaher